Executive summary
Through the use of Net Solving’s market leading (CaseCapture™) software, the Cystic Fibrosis Trust have been able to create a scalable, versatile and revenue generating registry that is respected worldwide.
This registry provides a comprehensive view and deep analysis into the progression of Cystic Fibrosis over time. With 100% participation from all specialist centres and clinics in the UK and a 99% consent rate from patients, this valuable data puts the Cystic Fibrosis Trust at the forefront of influencing policy and academia on the disease. Furthermore, the registry data is of such quality that randomised registry based clinical trials and pharmacovigilance studies can be run on it.
About the client
The Cystic Fibrosis Trust is the only UK-wide charity dedicated to fighting for a life unlimited by cystic fibrosis (CF) for everyone affected by the condition. Since it started in 1964 they have dedicated themselves to promoting excellence in research and clinical care, as well as providing practical support and advice to people with CF and their families. Their mission is to create a world where being born with CF no longer means a life-long struggle, when everyone living with the condition will be able to look forward to a long, healthy life.
The challenges
The CF Registry began its life at the University of Dundee in 1996 as a small research study.
The CF Registry had a reputation for excellence for many years, but they had ambitious plans for developing it to meet the evolving needs of people with cystic fibrosis - including creating bespoke study modules running seamlessly alongside the core system – They needed new state of the art technology to get them there.
The business case
The CF Registry is a high priority strategic program of work for them. The power of the registry often underpins applications for funding and steers their strategic direction as a charity:
The key factors in the procurement process were:
- Simple and intuitive system that needed minimal training
- Capability to run randomised registry based clinical trials.
- Scalability to allow many studies to be conducted on it
- High data quality and validations
- Smooth and comprehensive data migration process
"We had a lot of fundamental questions about cystic fibrosis that were going unanswered because it costs too much to run a traditional clinical study. Whereas a registry based clinical trial costs about a 10th as much as a normal study and is far quicker"
The Cystic Fibrosis Trust kicked off a procurement process and Net Solving were asked to join that process. They were known to the Trust through their notable work on the:
- SSNAP (Sentinel Stroke National Audit) – the single point for stoke data in the UK
- NELA (National Emergency Laparotomy Audit)
Net Solving came out on top of the procurement process due to the following factors:
- Extensive experience with registries
- Value for money
- Consultative approach
- Flexibility and scalability of system